INM Stock Analysis: Buy, Sell, or Hold?
INM - InMed Pharmaceuticals Inc. Common Shares
$1.59
0.07 (4.61%)
▲
5d:
-4.22%
30d:
+112.48%
90d:
+71.35%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When INM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INM shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: INM shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: INM is currently trading at $1.59, which is considered extended relative to its 30-day fair value range of $0.61 to $1.54.
Technical Outlook: Technically, INM is showing sideways momentum. Immediate support is located at $1.42, while resistance sits at $1.99. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: INM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+1157.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INM is showing sideways momentum. Immediate support is located at $1.42, while resistance sits at $1.99. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: INM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+1157.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.61 -
$1.54
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+4.6%)
- BULLISH: Trading 1157.9% below Wall St target ($20.00)
Trading Range Analysis
30-Day Trading Range
$0.61 -
$1.54
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.42
Resistance Level
$1.99
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Wall Street Target
$20.00
(+1157.9%)
Revenue Growth (YoY)
-26.2%
Profit Margin
-172.2%
Share & Embed Analysis
Last updated: June 03, 2026 10:05 PM ET
Data refreshes hourly during market hours. Next update: 11:05 PM
Data refreshes hourly during market hours. Next update: 11:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 55 HOLD |
